S TEPHANIE SALAZAR
*** **** *******, **********, ** 35226
909-***-**** ************@*****.***
SUMMARY OF QUALIFICATIONS
Over 5 years experience as a nurse practitioner with specialty preparation in Pulmonary/Critical Care/Sleep medicine. Focused, thorough, organized, enjoy sharing knowledge and practice judicious use of available resources.
EXPERIENCE
Nurse Practitioner
May 2018 to present
Eastern Hospital Medicine, PC
Birmingham, AL
Providing weekend coverage by rounding at skilled facilities: St Martins in the Pines and Trussville Rehab.
Nurse Practitioner
March 2018 to present
Healthstat
BB&T at 2501 20th Pl S.
Birmingham, AL 35223
Sole provider office for acute episodic and chronic disease management.
Adjunct Professor
September 2014 to March 2018
Loma Linda University School of Allied Health, Loma Linda, CA
Preceptor for Physician Assistant students from Loma Linda University. Specialty education for pulmonary and sleep disorders as well as inpatient, acute care internal medicine and medical/surgical assessment and treatment planning. Full-time, Monday through Friday. Noncompensated position.
Nurse Practitioner
September 2013 to March 2018
Beaver Medical Group, Banning, CA
Specializing in Pulmonary / Acute Care medicine and providing evaluation, diagnosis, and treatment of patients in the clinic and hospital setting. Focused on the individual needs of each patient. Multi-disciplinary approach to care and treatment of an underserved population in a community hospital. Consultation and follow-up for pulmonary and sleep disorders. Electronic Medical Records
Staff Registered Nurse, ICU
August 2004 to July 2013
San Gorgonio Memorial Hospital, Banning, CA
Primary care of medical-surgical ICU patients, McKesson EMR, Cross trained to ER, DOU, Preop, PACU. Charge RN, preceptor for RN students.
Staff RN, DOU
June 2002 to May 2003
Redlands Community Hospital, Redlands, CA
Primary care of step-down ICU patients, Meditech EMR, continuously changing census and workload, maintaining rapid pace and high endurance levels, recognizing how to best utilize personnel resources to deliver high quality patient care in a step-down ICU unit.
Staff RN
July 1999 to February 2002
Best Care Central Coast Home Health Agency, San Luis Obispo, CA
Independent formulation of treatment plans, extensive teaching for patients and their families, independent organization and delivery care, recognition of appropriate referrals and continuously advocating for patient safety, careful attention to billing requirements to optimize reimbursement.
Staff RN
October 1995-May 1999
Mary Washington Hospital Home Health
Responsible for management of local territory. Independent formulation of treatment plans, extensive teaching for patients and their families, independent organization and delivery care, recognition of appropriate referrals and continuously advocating for patient safety, careful attention to billing requirements to optimize reimbursement.
EDUCATION
California State University Dominguez Hills, 2013
Carson, CA
MSN Family Nurse Practitioner
Georgia State University, 1993
Atlanta, GA
BSN Nursing
LICENSES AND CERTIFICATIONS
Alabama Registered Nurse 1-100089 exp. 12/31/2018
California Nurse Practitioner, License #23393
California Registered Nurse, License #558544
Certified Family Nurse Practitioner valid thru 8/2023
Critical Care Certified RN (AACN) 8/2008
BLS/ACLS valid thru 6/2019
Critical Care Nursing Course 2/2006
RELEVANT SKILLS
Excellent EMR proficiency
Microsoft Word, Excel, and PowerPoint
PROFESSIONAL AFFILIATIONS
American Association of Nurse Practitioners (AANP)
Sigma Theta Tau International Honor Society of Nursing – Xi Theta Chapter (SSTI) - 2011
National Society of Leadership and Success – 2017
Honor Society of Phi Kappa Phi– 2017
RESEARCH CLINICAL TRIALS
Amgen – A Double-blind, randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG145 is Used in Combination with Statin Therapy in Patients with Clinically Evident Cardiovascular Disease. Protocol 20110118
Odyssey – A Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Evaluate the Effects of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome. Protocol EFC11570 (SANOFI)
TASLEY – A phase 111 Trial to Confirm the Anti-anginal effect of T89 in Patients with Stable Angina. Protocol T89-07-CAESA
Pfizer – A Phase 111 Double-blind, Randomized, Placebo-controlled, Parallel-Group Study to Assess the Efficacy, Long-Term Safety, and Tolerability of PF-004950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events. Protocol B-1481020
CDIFF – Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. difficile infection. Protocol H-030-014 (SANOFI)
Harmony Outcomes – A long term, randomized, double-blind, placebo-controlled study to determine the effect of Albiglutide, when added to Standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus. Protocol GLP1161714 (GSK)
DAL301 – Phase 111, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapid on Cardiovascular (CV) risk in genetically defined population with a recent Acute Coronary Syndrome (ACS)
CHAMP-HF – Observational Registry of Treatment Patterns in U. S. Heart Failure Patients with Reduced Ejection Fraction. Protocol CLCZ696BUS05
Pfizer – A Phase III, Placebo-controlled, Randomized, Observer Blinded Study to Evaluate
the Efficacy, Safety, and Tolerability of a Clostridium Difficile Vaccine in Adults 50 years of age and older. Protocol B509107